Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Localized Prostate Cancer”

3 trials

Showing 3 of 3 results

Early research (Phase 1)Study completedNCT03177460
What this trial is testing

Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 33
Very early researchLooking for participantsNCT06408298
What this trial is testing

HCQ in Resectable Localized Prostate Cancer

Who this might be right for
Resectable Localized Prostate Cancer
Lionel.D.Lewis, MD 20
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation